Computational Rational Design (CARD)
Using substrate interaction modeling and structural bioinformatics, we guide mutations in the donor/acceptor binding sites to predict changes in promiscuity and specificity.
Glycosyltransferases (GTs) are fundamental to the synthesis of complex carbohydrates, playing an increasingly vital role in Glycoprotein and Glycopeptide Drug Modification. Precise glycosylation is essential for drug efficacy, half-life, and immunogenicity. However, utilizing GTs for synthetic glycosylation faces critical challenges: the low availability and high cost of natural sugar nucleotide donors, poor enzymatic transfer efficiency, and the inherent difficulty in achieving complex, non-natural glycosylation patterns that enhance therapeutic profiles.
Our specialized enzyme optimization services and powerful engineering platforms are dedicated to addressing these biochemical and cost barriers. Our focus areas include: engineering GTs for broader sugar donor promiscuity (utilizing cheaper substrates), significantly improving transfer efficiency and regioselectivity, and creating novel GT variants to synthesize highly specific and complex glycan structures. Consult with our experts to design a customized strategy that elevates your glycosylation process to an industrial and therapeutic standard.
Get a QuoteThe large-scale, cost-effective utilization of GTs for drug modification is limited by these key factors:
Our engineering platforms are dedicated to resolving these complex stoichiometric and specificity limitations.
We apply integrated protein engineering strategies to enhance your target Glycosyltransferase:
Sugar Donor Promiscuity Expansion
We engineer the sugar donor binding pocket for increased tolerance, enabling the use of cheaper, more accessible activated sugar precursors.
Transfer Efficiency Improvement
Advanced enzyme optimization services focusing on improving k_cat and coupling the reaction with efficient sugar donor regeneration systems.
Regio- & Glycan Specificity Control
We use specificity engineering to achieve precise glycan linkage and to create novel GTs that synthesize specific, complex non-natural glycan structures.
Integrated Cascade Design
We design multi-enzyme cascade systems, combining GTs with donor regeneration enzymes for a streamlined, single-pot synthesis of glycosylated products.
Our experts are ready to apply these integrated capabilities to your specific glycoprotein or glycopeptide modification project.
We leverage a suite of cutting-edge platforms to deliver highly functional enzyme variants:
Computational Rational Design (CARD)
Using substrate interaction modeling and structural bioinformatics, we guide mutations in the donor/acceptor binding sites to predict changes in promiscuity and specificity.
Directed Evolution Workflows
We utilize HTS services coupled with sensitive glycosylation assays (e.g., coupled-enzyme assays) to rapidly evolve GTs for enhanced efficiency and non-natural substrate use.
Cell Surface Display for Engineering
Platforms like Yeast Surface Display are employed to screen large libraries of GT variants, particularly those requiring membrane localization, for improved activity or stability.
Comprehensive Enzyme Profiling
We offer full enzyme characterization, including kinetic analysis of both sugar donor and protein acceptor, and stability profiling under process conditions.
Optimized Enzyme Production
Specialized custom production services to achieve high yield and purity for membrane-bound or complex GTs in appropriate expression systems.
Partner with us to harness these platforms for your next glycobiology breakthrough.
Our enzyme optimization projects follow a flexible, milestone-driven workflow:
Technical communication is maintained throughout the project. We encourage potential clients to initiate a consultation to discuss their specific GT requirements and explore how our technologies can achieve their desired glycan structures and process cost reduction.
We provide comprehensive support, including:
How do you engineer GTs to use non-natural or cheaper sugar donors?
We use Active Site Analysis and Directed Evolution to identify and modify key residues in the donor binding pocket. This relaxes the specificity for the activated sugar moiety, allowing the use of analogs or simplified sugar precursors.
Can you improve the efficiency of a GT that exhibits poor activity?
Yes. Low activity is often due to poor k_cat or inefficient binding. We enhance efficiency by optimizing the active site tunnel using Rational Design, or by increasing the coupling with the donor regeneration enzyme in a cascade system.
What is the estimated timeline for creating a GT for a specific non-natural glycan?
Creating a GT with altered specificity requires complex engineering. A comprehensive project to synthesize a specific non-natural glycan structure typically requires 30-50 weeks, including library construction, selection, and validation of the precise linkage.
Do you offer services to identify novel GTs for challenging targets?
Yes. We provide advanced enzyme discovery services, utilizing AI-guided metagenomic analysis and genome database mining to discover new GT families with potentially broader substrate promiscuity for novel glycosylation targets.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis
Copyright © 2025 CD Biosynsis. All rights reserved.